Localization of GFP-Rad52 in stable human cell lines by Lovins, Rachel
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
2000




Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Lovins, Rachel, "Localization of GFP-Rad52 in stable human cell lines" (2000). Yale Medicine Thesis Digital Library. 2880.
http://elischolar.library.yale.edu/ymtdl/2880
LOCALIZATION OF GFP-RAD52 IN STABLE 









Permission to photocopy or microfilm processing 
of this thesis for the purpose of individual 
scholarly consultation or reference is hereby 
granted by the author. This permission is not to be 
interpreted as affecting publication of this work or 
otherwise placing it in the public domain, and the 
author reserves all rights of ownership guaranteed 
under common law protection of unpublished 
manuscripts. 





Digitized by the Internet Archive 
in 2017 with funding from 
The National Endowment for the Humanities and the Arcadia Fund 
https://archive.org/details/localizationofgfOOIovi 
Localization of GFP-Rad52 in Stable Human Cell Lines 
A Thesis Submitted to the 
Yale University School of Medicine 
in Partial Fulfillment of the Requirements for the 





9. h 2000 
Acknowledgments 
I would like to thank my advisor, Nancy Maizels, Ph.D., for her generous 
support and for making it possible for me to pursue this project. I would like to thank 
Yilun Lui, for her patient guidance and instruction, and for showing me the beauty of 
green fluorescent protein under the microscope. In addition, I would like to thank Ashley 
Eversole for her welcome companionship in the tissue culture room and for being a 
tremendous help in getting my “lab legs”. 
I would especially like to acknowledge Marina Piccioto, Ph.D. for her warm and 
helpful encouragement and sense of humor, and for use of her computer. Finally, I wish 
to thank my husband Dan and my son Ben for their support as I completed this final 
requirement for my MD. 




LOCALIZATION OF GFP-RAD52 IN STABLE HUMAN CELL LINES. 
Rachel Lovins, Yilun Liu, and Nancy Maizels. Departments of MB&B and 
Genetics, Yale University School of Medicine, New Haven CT. 
We have examined the expression and localization of Rad52 in human cells. Rad52 
is a protein shown to be essential to recombination and repair in yeast. Biochemical studies 
have demonstrated that Rad52 has similar in vitro functions in mammals, but its in vivo role 
in mammals is unclear. 
In our experiments we analyzed localization of Rad52 tagged with Green 
Fluorescent Protein (GFP). We used an LXSN retroviral vector containing GFP-Rad52 to 
infect a variety of human cell lines including fibroblasts and lymphocytes. Infected cells 
were selected with G418. Fluorescent microscopy showed that HT1080, Akata and 50% of 
the HeLa cells expressing GFP-Rad52 had the signal localized to the nucleus. In these cells 
the GFP signal was either concentrated in the nucleoli or excluded from it. These results 
were consistent with previous studies using mouse cells. GFP-Rad52 expression in Raji 
(EBV-transformed pre-B cells) was very weak making it difficult to evaluate. The GFP 
signal in Saos-2 (cells lacking the tumor suppressor gene p53) and many of the HeLa cells 
was localized to the cytoplasm and excluded from the nucleus. 
We conclude that in human cells GFP-Rad52 localizes mainly to the nucleus and 
exhibits the patterns of either exclusion from the nucleoli or concentration in the nucleoli 
that has been demonstrated in murine cells. The cause of the high degree of cytoplasmic 
non-nuclear distribution in HeLa and Saos-2 cells is unknown but may be related to cell 
death and deserves further study. 

Table of Contents 
1. Introduction.1 
1.1 Anticipated Results.6 
2. Statement of Purpose.7 
3. Materials and Methods.7 
3.1 Cell Culture.  
3.2 Retroviral construct.8 
3.3 Infection and creation of stable cell ines.9 
3.4 Visualization and Microscopy.10 
4. Results. 10 
4.1 Infection of amphoteric cell ine.10 
4.2 Selection of adherent cells. 2 
4.3 Expression and Localization of GFP-Rad52 in adherent cells.12 
4.4 Selection of non-adherent cells.16 
4.5 Expression and Localization of GFP-Rad52 in non-adherent cells.16 
5. Discussion.17 
5.1 Efficiency of Transduction.17 
5.2 Localization of Signal.18 
5.3 Conclusions.19 
6. References 20 

1. Introduction 
All cells must be able to repair breaks in their DNA in order to survive. 
Double strand DNA breaks occur during a variety of processes including meiotic division, 
V(D)J recombination in lymphocytes, and as a result of radiation and chemically induced 
damage. Two main pathways have been identified for repairing broken double strand DNA 
in eukaryotic cells: end to end rejoining using Ku protein, and homologous recombination 
(1). Homologous recombination in eukaryotic cells has been shown to involve several 
proteins including Rad52. 
Rad52 is a member of the Rad52 epistasis group, a family of genes involved in 
DNA repair which includes Rad5Q-55, Rad57, Rad59, MRE1J, and XRS2 (2, 3) (4, 5). 
The Rad.52 gene is located on chromosome 12p 12.2-p 13 in humans (2)) and the protein it 
encodes is 418 amino acids in length. The protein contains several domains of defined 
function including a DNA binding domain at the N terminus, domains that allow interaction 
with Rad51 and Replication Binding Protein (RPA), and a self-association domain (6) (Fig. 
1). 
Fig. 1 Human Rad52 and its interaction domains 
Rad52/DNAj |Rad52/Rad52 Rad52/RPA Rad52/Rad51 "1 
Fig. ! - The human Rad52 protein and its known protein interaction domains including self 




Recombination involves genetic exchange between DNA sequences. In meiosis, 
(exchange between homologous DNA sequences on two copies of the same chromosome), 
this allows for the distribution of separate alleles to the next generation. Recombination can 
also occur in a site-specific fashion when foreign DNA is either insertedinto or excised 
from genomic DNA (Fig. 2). 
Fig 2. Homologous Recombination 
Strand exchange: These types of reactions are promoted by RecA and involve 
Rad52, Rad5 1 and RPA in yeast. On the left is an example of non-reciprocal strand exchange 
between single stranded and double stranded DNA. On the right is an example of reciprocal 
strand exchange between duplex DNA as occurs in meiosis. 
Rad51 is the eukaryotic homologue of RdcA, a critical prokaryotic recombination 
protein. Working in conceit with other proteins, Rad51 is also integral to the DNA 
recombination/repair pathway in yeast (3, 7). Yeast with a null mutation in Rad51 
accumulate double stranded breaks during meiosis (8). 
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It is Rad52, however, which is the most critical recombination repair protein in S. 
cerevisiae (5, 9). Rad52 is required for mitotic recombination in yeast and Rad52 mutants 
are unable to reproduce, are hypersensitive to ionizing radiation and have deficiencies in 
homologous and ribosomal DNA (rDNA) recombination (5, 10, 11). Biochemical studies 
have shown that Rad52 binds to both single stranded and double stranded DNA and it has 
been known to synergize with Rad51 in strand transfer reactions (1,9, 12-14). The 
probable role of Rad52 in homologous recombination during meiosis in germ cells may 
explain the high levels of the protein that have been found in the testes of chicken and mice 
(2). 
Rad52 has also been shown to be necessary for Replication Protein A (RPA)-single 
strand DNA annealing in some conditions (15). During strand exchange RPA appears to 
compete with Rad51 for DNA interaction sites. Rad52 appears to inhibit RPA/DNA 
binding, allowing Rad51 to bind to the DNA (16, 17). This might explain why Rad52 acts 
as a catalyst in Rad51 reactions when Rad51 is at subsaturating concentrations (18). In 
yeast therefore, Rad52, Rad51 and RPA are all necessary to stimulate strand exchange. 
In addition to associations through the known interaction domains, Rad52 is most 
likely also associated with other proteins involved with DNA repair. BRCA1 and BRCA2 
have been shown to interact with Rad51 and may be additional cofactors in Rad51/Rad52 
mediated double strand break repair (19-21). Since Rad51 is known to associate with 
Rad52 and BRCA1 and BRCA2, it has raised the possibility that Rad52 is involved in the 
development of early onset breast cancer, although this is controversial (22, 23). 
There is a high degree of conservation of Rad52 across species (Table 1). The 
conservation between yeast and mammalian Rad52 proteins is mainly confined to the N- 
terminal DNA binding region. The Rad52/Rad51 and Rad52/RPA interaction sites, 
however, appear not to be highly conserved between yeast and mammals. There is no 
homology to the Rad51 interacting domain of human Rad52 in yeast (24). In addition, the 

4 
RPA binding region of human Rad52 has very limited homology between species and only 
~7% identity between yeast and human (6). Since Rad52 is known to interact with Rad51 
and RPA in both yeast and mammals, the reason for the lack of conservation in these 
domains remains unclear at this time. It may be due to differences in the primary structure 
of RPA and Rad51 across species. 
Table 1 
Comparison of Human Rad52 Amino Acid Composition With Other Organisms 




Mouse 431 9 80.5 71.7 
Chicken 432 7 73.0 57.8 
S. cerevisiae 501 12 51.0 30.8 
K. lactice 438 11 51.8 30.5 
S. Pombe All 8 49.6 30.7 
Percentage similarity and identity of amino acids of the Rad52 of several organisms to the human 
protein. There is a great deal of conservation between murine and human Rad52. Identity between 
species is mainly in the N-terminus region (2). 
In contrast to yeast, genetic analysis in mammals has shown that Rad52 knockout 
mice, while demonstrating slightly reduced homologous recombination, do not show 
increased sensitivity to ionizing radiation or chemically induced double strand breaks, or 
any impairment in viability, fertility or immune function (4). This is especially surprising 
given that in vitro studies have strongly suggested that Rad52 plays an important role in 
DNA repair by synergizing with Rad51 (15, 18). 
Electron microscopic studies have shown that human Rad52 binds to single strand 
ends of linear DNA and forms molecular bridges in large protein networks. Thus, both 
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yeast and human Rad52 can facilitate the formation of molecular complexes and the 
recruitment of Rad51. This suggests several roles for Rad52 in vivo, including protecting 
free DNA ends from exonuclease digestion, recruiting other proteins such as Rad51 and 
enhancing homologous pairing (1,25). If human and yeast Rad52 have the same function 
in vitro, why do they have such different effects in vivol 
It is of interest to determine whether Rad52 actually does have a different function in 
mammalian cells than in yeast cells, or whether the apparent lack of effect of the murine 
Rad52 deletion reflects the ability of mammals to rely on alternate methods of DNA repair. 
There is some evidence that in S. cerevisiae, Rad55, Rad57 and Rad59 have overlapping 
function with Rad52 since over-expression of Rad52 can suppress mutations found in 
Rad55, Rad57 and Rad59 mutants (26). Alternatively, the Ku mediated pathway may 
compensate for the absence of Rad52 in mammalian cells. 
Despite the lack of the expected phenotype in mice with a mutation in Rad52, there 
are several studies that have pointed to a clear role for Rad52 in DNA repair/recombination 
in mammalian cells. Over-expression of human Rad52 has been reported to confer 
enhanced resistance to gamma-rays and induce homologous intra-chromosomal 
recombination in monkey cells (27). Yeast Rad52 introduced into human HT1080 cells 
caused the cells to have a markedly increased frequency of inter-plasmid homologous DNA 
recombination (28). In addition it has recently been observed that expression of Rad52 
tagged with green fluorescent protein (GFP-Rad52) in murine cells confers greater survival 
after damage with ionizing radiation. (Liu and Maizels, submitted). 
To investigate the involvement of mammalian Rad52 in DNA repair in vivo, Yilun 
Liu in the laboratory of Nancy Maizels at Yale University School of Medicine has studied 
the localization of Rad52 in murine spleen cells during the cell cycle and after induction of 
DNA damage by ionizing radiation. By imaging cells expressing GFP-Rad52, Liu 
demonstrated that the protein was distributed throughout the nucleus but typically excluded 
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from the nucleoli during G1 phase; highly concentrated in the nucleoli during S phase 
(during rDNA synthesis); and distributed throughout the cell during M phase (when the 
nuclear envelope was not intact) (29). Rad52 has been shown to participate in rDNA 
recombination in yeast (30, 31). This offers an explanation as to why Rad52 localizes in 
the nucleolus during S-phase in mice. Although it is likely that it is involved in the same 
rDNA process in mammals, this has not been conclusively shown. 
Localization of GFP-Rad52 has also been studied in murine cells treated with 
ionizing radiation to cause DNA double strand breaks. Following treatment with 5 Gy, 
GFP-Rad52 was shown to be localized to multiple foci within the nucleus. Rad50, a DNA 
repair protein known to be essential to mammalian viability (32), also relocalized to form 
foci and colocalized with GFP-Rad52 (29). 
In vitro studies have shown that human Rad51 binds directly to Rad52, as discussed 
above. In vivo experiments have shown that murine Rad52 also colocalizes with murine 
Rad51 after radiation induced DNA damage, further strengthening the association of Rad52 
with the DNA repair complex in mammals (Liu and Maizels, submitted). The foci may 
correspond to sites of active DNA repair. 
1.1 Anticipated Results 
Missing from the literature to date are in vivo studies of Rad52 localization and 
response to double strand DNA damage in human cells. In addition, further studies are 
needed to clarify the relationship of Rad52, RPA, BRCA1 and BRCA2 in human cells. 
Because of the high degree of homology between mouse and 
human Rad52, it is expected that Rad52 will function in a similar fashion in human and 
mouse cells. It is possible, however, that different human cell lines may rely on Rad52 to 
varying degrees. For example, developing lymphocytes undergo V(D)J rearrangement to 
generate specific antibodies. This occurs in the thymus and spleen and elevated Rad52 
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levels have been found in murine thymus and spleen tissues (4). Therefore, Raji and Akata 
(EBV-transformed B cells) may show enhanced Rad52 activity. 
One especially critical protein in mammalian cells is p53. Sometimes referred to as 
“the guardian of the genome”, p53 normally induces cell cycle arrest or apoptosis when 
DNA damage needs to be repaired. Cells lacking this safeguard accumulate DNA damage, 
and it is therefore not surprising that p53 mutation contributes to many types of cancers. 
As p53 mutant cells lack the molecular machinery to recognize some of their own double 
strand breaks, it is possible that they may exhibit decreased recruitment or expression of 
Rad52. 
2. Statement of Purpose 
We sill study the localization of Rad52 in human cells by generating stable human 
cell lines which express GFP-Rad52 via retroviral transduction. 
3. Materials and Methods 
3.1 Cell Culture 
All cells were obtained from previously frozen cells lines or split from existing cell 
lines maintained in the laboratories of Dr. Nancy Maizels and Dr. Alan Weiner at Yale 
University School of Medicine. Adherent cells including the murine cell lines PA317 and 
PE501, and human cell lines HT1080, HeLa, and Saos-2 (p53 mutant) were cultured in 
DMEM (Gibco), 10% fetal bovine serum, 100 U/ml penicillin and 100 (ig/ml streptomycin. 
Non-adherent cells including the human B cell lines Raji and Akata were cultured in RPMI 
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1640 (Gibco), 10% fetal bovine serum, 100 U/ml penicillin, 100 jig/ml streptomycin and 10 
pM B-mercaptoethanol. All cells were incubated at 37°C in 5% C02. 
3.2 Retroviral Construct 
To facilitate visualization of Rad52, we used a construct in which-murine Rad52 was 
tagged with Green Fluorescent Protein (GFP) using a gene derived originally from the 
jellyfish Aequorea victoria (33). The construct was generated and generously provided by 
Yilun Liu in the laboratory of Dr. Nancy Maizels, Yale University School of Medicine (Fig. 
3). The cloning and generation of this construct have been described previously (29). The 
GFP-Rad52 fusion gene was carried in the retroviral vector LXSN. The backbone of the 
vector was derived from the murine retroviruses MoMLV and MoMSV (34). The vector 
carries the gene for G418 (neomycin) resistance as a positive selection marker and was 
propagated in the murine ecotropic retrovirus packaging cell line, PE501. This virus- 
producing cell line (referred to as PE501/GFP-Rad52) was maintained by culture in 
DMEM with 1 mg/ml of G418 for selection. 
Fig. 3 LXSN Retroviral Vector For GFP-Rad52 
LXSN LTR GFP Ra'd52| NEO LTR 
Fig. 3 The LXSN retroviral vector containing GFP-Rad52. This construct contains a gene 
for neomycin (G418) resistance (yellow box). The GFP is attached to the N-terminus of 
Rad52. Arrows indicate promoters and direction of transcription. Indicated genetic regions 
are: L.TR - long terminal repeat. GFP - Green Fluorescent Protein. SV - Simian Virus 
40. Neo - gene for neomycin resistance. 
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3.3 Infection and creation of stable cell lines. 
Infection of adherent cells- 
To create an amphoteric retroviral stock, when PE501/GFP-Rad52 cells were 
approximately 80% confluent, excess medium was removed, 8 ml of fresh medium was 
added, and culture continued for one hour. Retrovirus was separated from the cells by 
filtration through a 0.45 micron filter. For infection of PA317 cells (the amphoteric 
packaging line), excess medium was removed from an actively proliferating culture of 
PA317 cells and replaced with a cocktail of 40% retrovirus stock, 40% DMEM with 8 
jig/ml polybrene (Sigma), and 20% fresh medium. This procedure was repeated every hour 
for a total of three times and the PA317 cells were then left to incubate for 24 hours. The 
cells were then selected by culture in DMEM containing 1 mg/ml G418. The selection 
medium was changed every day for four days to remove dead cells, and then approximately 
every other day for the duration of the experiment. Fourteen days after infection, retrovirus 
from the infected PA317 cells was harvested through filtration and used to infect the human 
adherent cells in the same manner described above. Filtration to separate virus from host 
was essential: omission of this step in one set of experiments resulted in mixed cell 
populations. 
Infection of Non-Adherent Cells 
The non-adherent, B lymphocyte lines Raji and Akata were infected by co¬ 
incubation with amphoteric packaging cell line PA317/GFP-Rad52 as follows. Medium 
from a flask of PA317/GFP-Rad52 cells was removed and replaced with 30% non-adherent 
cells in suspension at a concentration of 106 cells/ml, 40% RPMI containing 8 pg/ml 
polybrene, and 30% fresh medium. After 24 hours, the non-adherent cells were removed by 
aspiration, spun down resuspended in RPMI. The infection process was then repeated for a 
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total retrovirus exposure time of 48 hours. Non-adherent cells were then removed, 
centrifuged and resuspended in a separate flask containing 1.5 mg/ml G418 in RPMI. The 
selection conditions were verified by examining parallel Raji and Akata cell control cultures 
for cell death. On day five the G418 resistant cells were expanded by transfer into larger 
flasks and feeding and selection continued. This method produced transductants of Akata 
but not Raji despite numerous attempts. 
3.4 Visualization and Microscopy 
To visualize GFP-Rad52 in non-adherent cells, the cells were harvested by 
centrifugation, resuspended in PBS, then centrifuged onto glass slides at 800 rpm for 4 
minutes in a Cytospin 3. To visualize the GFP signal in adherent cells, the cells were grown 
on tissue culture chamber slides (Nalge Nunc International) and then washed once with 
PBS before observation under the microscope. Both types of cells were then examined 
under fluoroscopic magnification. Cell structure was also visualized using transmitted light 
when possible. 
4. Results 
4.1 Infection of amphoteric cell line 
Although the viral construct containing GFP-Rad52 (Fig. 3) had been successfully 
used to infect several types of murine cells, it had never been introduced into human cells. 
We therefore used the ecotropic, murine PE501/GFP-Rad52 retrovirus packaging cell line 
to infect PA317, a packaging cell line which produces virus capable of infecting human 
cells. The infection was carried out by placing filtered virus-containing medium from the 
ecotropic cell line into flasks containing PA317. After 24 hours the newly infected cells 
were selected in RPMI medium containing G418 to select for transformed cells. After an 

additional 24 hours, many of the cells in the newly infected flasks were dead, and within 
several days it was apparent that small colonies were thriving. By day 5 the cells had 
completely recovered and were maintained in their selection medium. To verify that the 
packaging lines expressed GFP-Rad52, PE501/GFP-Rad52 and PE317/GFP-Rad52 were 
grown on tissue chamber slides and imaged under fluorescent microscopy. The GFP- 
Rad52 was localized to the nuclei in all cells, either concentrated in or excluded from the 
nucleoli (Fig 4). These results are identical to those previously described in studies of 
GFP~Rad52 in murine fibroblasts (29). 
Fig. 4 Expression of GFP-Rad52 in Murine Fibroblasts 
Fig. 4 -Localization of GFP-Rad52 in PE501/GFP-Rad52 cells. A - Examples of cells showing nuclear 
localization with exclusion from the nucleoli, B - A group of cells showing nuclear localization with 
concentration in the nucleoli. 

4.2 Infection and selection of adherent human cells 
After a stable line of PA317/GFP-Rad52 cells was produced, the human adherent 
cells were infected. Adherent cells chosen for infection included the fibroblast derived cell 
lines HeLa and HT1080, and the p53 mutant cell line Saos-2. By day 3 of selection, many 
of the Saos-2 and HT1080 cells were dead, but the HeLa cells remained vigorous and 
confluent. The survival of HeLa cells was measured as function of G418 concentration. 
This showed that HeLa cells required a G418 concentration of 1.0 mg/ml for selection, 
twice that of the other human adherent cells. 
Selection medium was changed every 1-2 days. By day 9 all the adherent cells were 
fully recovered and had reached confluence. For observation, cells were split 1:20 onto 
tissue culture chamber slides. When -70-90% confluent they were imaged under 
fluorescent and transmitted light. 
4.3 Expression and localization of GFP-Rad52 in adherent cells 
HT1080 
The fibroblast cell line HT1080 showed strong GFP signals in many cells. The 
signal was localized mainly to the nucleus and often concentrated in the nucleolus. Some 
cells showed the signal localized to the nucleus but excluded from the nucleoli (Fig. 5). The 
localization of GFP-Rad52 within the cells was confirmed by phase imaging (Fig. 5). 
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Fig. 5 Expression of GFP-Rad52 in HT1080 Ceils 
Fig. 5 - Phase and fluoroscopic images of HT1080 cells expressing GFP-Rad52. The 
protein is localized to the nucleus and concentrated in the nucleoli. Left, transmitted light; 
Center, GFP-Rad52; Right, merged image. 
HeLa 
In about 50 % of cells which expressed GFP-Rad52, the protein was localized to the 
nucleus. In these HeLa cells, the protein was often concentrated in the nucleolus (Fig. 6). 
A possibly significant finding in this cell line was that the other 50% of cells expressing 
GFP-Rad52 showed cytoplasmic localization with exclusion from the nucleus (Fig. 6). 
These cells, however, were round and in overly confluent areas suggesting that they were 
end-stage or dying. 

Fig. 6 Expression of GFP-Rad52 in HeLa Cells 
Fig. 6 Phase and fluoroscopic images of GFP-Rad52 expression in HeLa cells. A - Cells 
showing nucleolar localization. B Cells showing nuclear localization. C - Cells showing 
cytoplasmic localization. For A and B: Left, transmitted light; Center. GFP-Rad52; Right, 
merged image. 
Saos-2 
The GFP-Rad52 signal in Saos-2 cells was much weaker than in the other adherent 
cell lines and was expressed in very few cells (-1/500). It faded quickly under prolonged 
fluoroscopic exposure making the capturing of images difficult. In most cells, GFP-Rad52 
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was localized to the cytoplasm (Fig. 7). No Saos-2 cells demonstrated a clearly defined 
nuclear or nucleolar localization. 
Fig. 7 Expression of GFP-Rad52 in Saos-2 cells 
Fig. 7 Patterns of GFP-Rad52 expression in Saos-2 cells. A - An example of one cell with 
GFP-Rad52 localized to the cytoplasm. B - Three distinct cells showing the identical pattern. 
Left, transmitted light; Center, GFP-Rad52; Right, merged image. 
4.4 Selection of non-adherent human cells 
The EBV transformed B cell lines Raji and Akata were infected numerous times 
under several conditions. Two weeks after selection almost all Akata cells were dead, but a 
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small percentage of Raji cells began proliferating. About ten fold more Raji than Akata cells 
survived the selection. Of note, control Raji cells with a high resistance to G418 behaved 
unusually. About 80% of Raji cells in our control samples existed as single cells 
distributed evenly in their suspension medium. The other 20% existed in clumps with the 
appearance of a bunch of grapes. The G418 resistant cells were all in clumps. It was 
possible to separate the cells by pipetting the suspension fluid up and down numerous 
times, but within 24 hours they would re-aggregate and float to the bottom of the flask. 
4.5 Expression and Localization of GFP-Rad52 in non-adherent 
On day 9 post-selection the cells were imaged using fluoroscopic 
microscopy. Although only a small percentage (approximately 0.25%) of Akata cells 
expressed a clear signal, the GFP was easily visualized and localized to a round structure 
presumed to be the nucleus (Fig. 8). These images are consistent with both concentration in 
the nucleoli (figure on the right) and exclusion from the nucleoli (image in the center) (Fig. 
8). The GFP signal in Raji was very faint and present in a small number of cells (not 
shown). 
Fig. 8 Expression of GFP-Rad52 in Akata Cells 
Fig. 8 GFP-Rad52 expression in Akata cells. The signal appears to be confined to the nucleus. 

5. DISCUSSION 
5.1 Efficiency of Transduction 
The retrovirus vector containing GFP-Rad52 which we used to infect human cells 
has been shown to be effective in transducing murine cells. We have shown that the same 
construct is capable of infecting human cells, and have generated transductants of four 
human cell lines which stably express GFP-Rad52: F1T1080, FleLa, Saos-2 and Akata. We 
saw a variety of degrees and patterns of expression of GFP-Rad52 in the different 
transductants. The variety was expected but the reasons behind it are unclear. Why was the 
efficiency so much lower than in murine cells? The answer may lie in the vector we used: 
LXSN, with a MoMLV derived LTR promoter region. 
Several studies have compared gene expression in transduced cells with different 
vectors. Although the genes used in these studies were not Rad52, the results are still 
significant. One study comparing LXSN to a MFG, another LTR-based retroviral vector, 
showed that LXSN demonstrated only 1-2% of the efficiency of the MFG vector in human 
cells, and 5-10% of the MFG efficiency in mouse cells. Viral titres using MFG were 
higher than in MoMLV derived vectors in all cell lines (35). 
Even when rates of transduction are the same, other vectors may produce higher 
rates of gene expression. The MNDeGFPSN vector has similar transduction rates to LXSN 
but 4-8 fold higher expression (36). Although MoMLV vectors are widely used in gene 
therapy experiments, both the MNDeGFPSN and the MFG vectors are more efficient. 
Vector inefficiency, therefore, may explain some of the difference in expression between 
human and murine cells in our experiment. 
Regardless of the nature of the vector, it is likely that the structure and function of 
different cells as well as their individual innate resistance to G418 accounted for some of the 
variance in expression of GFP-Rad52 that we observed. Future studies looking at the 
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localization of Rad52 in response to DNA damage, during the cell cycle, and in 
lymphocytes in response to activation of immunoglobulin switch recombination, could help 
clarify the role of the cells' individual phenotype in Rad52 expression. It is also possible 
that the small degree of variation in the primary structure of human and mouse Rad52 
contributes to the observed differences in expression. Future studies using human Rad52 
instead of murine Rad52 in human cells may show different results. 
5.2 Localization of Signal 
Most of the GFP-Rad52 in the cells we observed was localized to the nucleus. The 
nuclear signal was either concentrated in the nucleolus or excluded from the nucleolus. 
These findings are consistent with previously described localization of GFP-Rad52 in 
mouse cells (29). In mouse cells the signal is concentrated in the nucleoli during both S 
phase, during rDNA synthesis, and G0, when the cell is at rest (29). The presence of GFP- 
Rad52 in the nucleolus suggests that mammalian Rad52 is involved in rDNA recombination 
as it is in yeast, but we can not rule out that Rad52 is sequestered in the nucleolus for other 
reasons. As in previous studies (29), cells showing nuclear localization with exclusion 
from the nucleolus may be in G, phase. Future studies examining the localization of GFP- 
Rad52 in human cells during the cell cycle will help answer these questions. 
Interestingly, the signal in Akata cells did not appear to be clearly associated with the 
nucleolus. This is significant because previous studies with activated primary murine 
lymphocytes showed GFP-Rad52 concentrated in the nucleolus in the great majority of 
cells (29). Conclusions from our study are limited, however, due to the low number of 
Akata cells expressing the protein and the weakness of the signal. 
We are still left searching for an explanation for the cytoplasmic localization of 
GFP-Rad52 in a majority of Saos-2 and HeLa cells. Is there something about these cells 
that causes the nucleus to deny access to the GFP-Rad52 protein? Do the Saos-2 cells, as 
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hypothesized in the introduction, fail to recruit the protein to the nucleus since they are blind 
to their double strand DNA defects? 
The question arises of whether this cytoplamic distribution is related to cell 
pathology or death. Although the Saos-2 cells which showed this distribution appeared to 
be growing normally, they are inherently unhealthy. The HeLa cells with this expression 
pattern may have been dying. HeLa cells are normally diamond shaped and adhere to the 
bottom of the culture plate. When they become confluent the cells grow on top of eachother 
in a spherical shape. The cells we observed with cytoplasmic Rad52 distribution were 
round in shape and in areas of over-confluence. Perhaps a sick or dying cell banishes 
Rad52 from the nucleus because it has given up on DNA repair. It would be of great 
interest to see if these finding hold true in future studies. 
5.3 Conclusions 
In summary we have created lines of Akata, HeLa, and HT1080 cells which stably 
express GFP-Rad52. Although there was expression in Saos-2 and Raji cells, it was not 
sufficient to allow for evaluation. Of note, the localization in human cells was consistent 
with that in murine cells except for the cytoplasmic localization in HeLa and Saos-2-cells. 
Since in vitro studies show the same biochemical properties of Rad52 for yeast and 
mammalian DNA, how do we explain the difference in genetic results, which appear to show 
that deletion of mammalian Rad52 has little effect? As stated in the Introduction, it may be 
that mammalian cells rely more on Ku or Rad52 homologues. Still, if any possibility exists 
that Rad52 plays an important role in DNA repair or in tumorigenesis in mammals, it is 
essential to understand the function of this protein in humans. Even if the absence of 
Rad52 is proven not to be detrimental to human cell function and life-span, the question 
remains as to what benefit may come from its over-expression. Since GFP-Rad52 confers 
enhanced survival to cells damaged with ionizing radiation (Liu and Maizels, submitted), 
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could there be a role for gene therapy with Rad52 in patients who have undergone healthy- 
tissue damage after radiation therapy? Does Rad52 have a role in repairing damage to the 
DNA of telomeres and therefore in keeping the aging process in check (37)? These 
questions raise exciting possibilities and demand additional research. 
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